275 related articles for article (PubMed ID: 22258237)
1. HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.
Monel B; Beaumont E; Vendrame D; Schwartz O; Brand D; Mammano F
J Virol; 2012 Apr; 86(7):3924-33. PubMed ID: 22258237
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
3. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
[TBL] [Abstract][Full Text] [Related]
4. A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.
Brandano L; Stevenson M
J Virol; 2012 Feb; 86(4):2347-59. PubMed ID: 22156517
[TBL] [Abstract][Full Text] [Related]
5. Single-molecule imaging of HIV-1 envelope glycoprotein dynamics and Gag lattice association exposes determinants responsible for virus incorporation.
Pezeshkian N; Groves NS; van Engelenburg SB
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25269-25277. PubMed ID: 31757854
[TBL] [Abstract][Full Text] [Related]
6. The role of matrix in HIV-1 envelope glycoprotein incorporation.
Tedbury PR; Freed EO
Trends Microbiol; 2014 Jul; 22(7):372-8. PubMed ID: 24933691
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
8. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.
Wyma DJ; Jiang J; Shi J; Zhou J; Lineberger JE; Miller MD; Aiken C
J Virol; 2004 Apr; 78(7):3429-35. PubMed ID: 15016865
[TBL] [Abstract][Full Text] [Related]
9. Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.
Staubus AO; Alfadhli A; Barklis RL; Barklis E
Virology; 2019 Dec; 538():1-10. PubMed ID: 31550607
[TBL] [Abstract][Full Text] [Related]
10. Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix.
Bhatia AK; Campbell N; Panganiban A; Ratner L
Virology; 2007 Dec; 369(1):47-54. PubMed ID: 17706261
[TBL] [Abstract][Full Text] [Related]
11. Reverted HIV-1 Mutants in CD4
Lu W; Li TW; Phillips S; Wu L
Microbiol Spectr; 2021 Dec; 9(3):e0165321. PubMed ID: 34935422
[TBL] [Abstract][Full Text] [Related]
12. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
Mammano F; Kondo E; Sodroski J; Bukovsky A; Göttlinger HG
J Virol; 1995 Jun; 69(6):3824-30. PubMed ID: 7745730
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.
Kirschman J; Qi M; Ding L; Hammonds J; Dienger-Stambaugh K; Wang JJ; Lapierre LA; Goldenring JR; Spearman P
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212940
[TBL] [Abstract][Full Text] [Related]
14. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
Song YE; Olinger GY; Janaka SK; Johnson MC
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
[TBL] [Abstract][Full Text] [Related]
15. The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.
Santos da Silva E; Mulinge M; Lemaire M; Masquelier C; Beraud C; Rybicki A; Servais JY; Iserentant G; Schmit JC; Seguin-Devaux C; Perez Bercoff D
PLoS One; 2016; 11(9):e0161596. PubMed ID: 27598717
[TBL] [Abstract][Full Text] [Related]
16. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.
Alfadhli A; Staubus AO; Tedbury PR; Novikova M; Freed EO; Barklis E
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375589
[TBL] [Abstract][Full Text] [Related]
17. The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.
Murphy RE; Saad JS
Viruses; 2020 May; 12(5):. PubMed ID: 32429351
[TBL] [Abstract][Full Text] [Related]
18. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
Eastep GN; Ghanam RH; Green TJ; Saad JS
J Biol Chem; 2021; 296():100321. PubMed ID: 33485964
[TBL] [Abstract][Full Text] [Related]
20. Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein.
Alfadhli A; Romanaggi C; Barklis RL; Barklis E
J Virol; 2024 Feb; 98(2):e0174223. PubMed ID: 38193694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
